GHTC Event

RETURN ON INNOVATION: Why global health R&D is a smart investment for the United States

10:00–11:30 am
455 Massachusetts Ave., NW
Suite 1000
Washington, DC 20001
Hosted by: GHTC

As policymakers consider drastic cuts to our nation’s global health research infrastructure and as we confront the continued rise of global disease outbreaks, it’s more important than ever to examine how US investments are delivering value and impact at home and abroad. Global health research and development (R&D)—which saves lives in the world’s poorest places while generating economic and security returns for America—is a best buy for our nation.

Join us for a dialogue and briefing to launch a new report from GHTC and Policy Cures Research examining the return on investment from US government support for global health R&D, and discuss how we can leverage these report findings to advance global health innovation in uncertain times.
 
FEATURING:
RSVP HERE.

Light refreshments will be provided.

 

2017-07-20 10:00:00 2017-07-20 11:30:00 America/New_York RETURN ON INNOVATION: Why global health R&D is a smart investment for the United States As policymakers consider drastic cuts to our nation’s global health research infrastructure and our nation confronts the continued rise of global disease outbreaks, it’s more important than ever to examine how US investments are delivering value and impact at home and abroad. Global health research and development (R&D)—which saves lives in the world’s poorest places while generating economic and security returns for America—is a best buy for our nation.

Join GHTC for a dialogue and briefing to launch a new GHTC/Policy Cures Research report examining the return on investment from US government support for global health R&D, and discuss how we can leverage these report findings to advance global health innovation in uncertain times.

Featuring:
• Dr. Elizabeth Cameron, Senior Director for Global Biological Policy and Programs, Nuclear Threat Initiative; former Senior Director for Global Health Security and Biodefense, White House National Security Council
• Dr. J. Stephen Morrison, Senior Vice President and Director, Global Health Policy Center, Center for Strategic and International Studies
• Jami Taylor, Senior Director, Global Health Systems Policy & Partnerships, Johnson & Johnson
• Jamie Bay Nishi, Director, Global Health Technologies Coalition

PATH, 455 Massachusetts Ave., NW, Suite 1000 Washington, DC 20001z GHTC info@ghtcoalition.org
back